PubHealth.info® (An Information Portal on Public Health Issues / Topics, Presented in Collaboration with PakMed Biomedical Solutions)

[PubHealth.info Homepage] [Category Homepage] [Disclaimer/Copyrights] [Feedback]


Thank you for your kind visit to PubHealth.info®, an information portal created in technical collaboration with PakMed Biomedical Solutions * * * PubHealth.info® presents hundreds of thousands of informative Web pages on a variety of public health issues / issues * * * An ultimate source of information for teachers, students and research workers who need to find information on various public health issues, like population planning, contraception, HIV AIDS, STDs, maternal and child health, communicable and non-communicable disease, etc. * * * PubHealth.info® regularly updates the repository of these hundreds of thousands of informative Web pages * * * PubHealth.info® is one of the world's largest repositories and information portals with online Web pages on public health issues particularly those pertaining to developing countries!

PubHealth.info® (a subsidiary of PakMed) presents scientific information mainly based on abstracts of articles published on a variety of public health issues/topics, particularly encompassing population planning, disease prevention, maternal and child health, and communicable and non-communicable diseases (like HIV AIDS, malaria, etc) that are affecting a significant portion of population in developing and developed countries. Here you can find abstracts of articles published on a variety of public health topics under category "Contraception (Birth Control) and Family Planning". Contraception (birth control) is a regimen of one or more actions, devices, or medications followed in order to deliberately prevent or reduce the likelihood of a woman becoming pregnant or giving birth. Therefore contraception is the utilization of various and sundry surgical procedures, devices, practices, agents, or drugs with the intention of preventing conception or impregnation (pregnancy). Methods and intentions typically termed birth control may be considered a pivotal ingredient to family planning. Birth control is a controversial political and ethical issue in many cultures and religions, and although it is generally less controversial than abortion specifically.

Here you can find more than 42,000 article titles on "Contraception (Birth Control) and Family Planning" , along with their abstracts and bibliographic information (one of the world's largest collections of article titles on this topic), mentioned in various lists that are sorted/arranged according to the years of publication. You can view the bibliographic details and abstracts of these articles, by clicking the title of your required article. To view other lists of articles in the same category "Contraception (Birth Control) and Family Planning", please visit "Category Lists Homepage" or select a list from the following dropdown list of article titles.

 

List 59: Articles 29001-29500 (500 Articles)

To view other lists in the same category, please VISIT LISTS HOME PAGE or select a list from the above dropdown list of article titles
  1. Review and annotated bibliography of literature on male involvement in family planning.
  2. A review of data from the United States concerning the relationship of thromboembolic disease to oral contraceptives.
  3. A review of non-family planning program literature relevant to male oriented family planning programs.
  4. Review of reproductive biology/contraceptive development. Progress report.
  5. Rheumatoid arthritis and oral contraception. (Letter)
  6. (Rheumatoid arthritis and oral contraception: reply.) (Letter)
  7. Rheumatoid arthritis and oral contraceptives. (Editorial)
  8. Rheumatoid arthritis and oral contraceptives. (Letter)
  9. Riboflavin deficiency in women taking oral contraceptive agents.
  10. The right to contraception: contraceptive methods and their indications. [El derecho a la contraception: los metodos anticonceptivos y sus indicaciones.]
  11. The right to contraception: the contraceptive methods and their indications. [El derecho a la contraception: los metodos anticonceptivos y sus indicaciones.]
  12. Rise in female-initiated sexual activity at ovulation and its suppression by oral contraceptives.
  13. Risk approach for maternal and child health care. A managerial strategy to improve the coverage and quality of maternal and child health/family planning services based on the measurement of individual and community risk.
  14. Risk of adverse effects of contraception. [Riskbedoemning vid preventivmedelsraadgivning.]
  15. Risks and dangers of birth control measures: barrier contraception plus abortion. (The Ford report on adolescent sexuality)
  16. Risks and dangers of birth control measures: informed consent and the pill. (The Ford Report on Adolescent Sexuality)
  17. Risks and dangers of birth control measures: risks associated with the IUD. (The Ford Report on Adolescent Sexuality)
  18. Risks and dangers of birth control measures: teenage abortion statistics. (The Ford Report on Adolescent Sexuality)
  19. Risks and dangers of birth control measures: The medical risks of the pill. (The Ford Report on Adolescent Sexuality)
  20. (The role and importance of family planning programs as part of a basic needs approach to development assistance.) (Statement, April 20, 1978))
  21. Role of counseling in present-day family planning. [Radgivningens roll i dagens familjeplanering.]
  22. The role of family planning in family health and community development. [Le role de la planification familiale en relation avec la sante familiale et avec le developpement communautaire.]
  23. The role of family planning in recent rapid declines in fertility in developing countries: some findings from the World Fertility Survey.
  24. The role of FDA in contraceptive research. (Statement, March 9, 1978)
  25. The role of international family planning agencies in providing technical and financial assistance. (Statement, May 3, 1978)
  26. The role of midwives in birth control. [Ruolo delle ostetriche riguardo alla programmazione delle nascite.]
  27. Role of oral contraception in congenital malformations of offspring.
  28. The role of the psychiatrist in a family planning center. [Le psychiatre en centre de planification familiale.]
  29. (The role of the United States government in support of reproductive science and contraceptive development) (Statement, March 9, 1978)
  30. Role of traditional birth attendants with particular reference to their knowledge, attitudes and practices related to family planning.
  31. Role perception and performance of lower class black men and women in Barbados and their contraceptive behaviour.
  32. Rupture of hepatic adenoma and oral contraceptives. [Adenoma hepatico roto y anticonceptivos por via bucal.]
  33. Rural family planning program: Profamilia - Colombia.
  34. Safety and effectiveness of a new low-dose oral contraceptive: a three-year study of 1,000 women.
  35. Safety of contraceptive practice as compared to non-contraception.
  36. Safety of the long-acting injectable contraceptive Depo-Provera.
  37. The San Pablo experiment: educational strategies in family planning for rural workers.
  38. San Rafael: family planning promotion in a rural Salvadoren village.
  39. Scots sweetening the male contraceptive picture?
  40. Screening for gonorrhoea in a central London family planning clinic.
  41. Second report on intrauterine contraceptive devices.
  42. Secondary amenorrhea associated with the use of oral contraceptive steroids.
  43. Secondary effects of hormonal contraception on the breast. [Effets secondaires de la contraception hormonale sur les seins.]
  44. Selected audio visual aids for family planning programmes: resource list.
  45. Seminar on injectable contraceptives, Dacca, July 27, 1978. Recommendations and summary of proceedings.
  46. A sensitive approach to family planning motivation in Malaysia.
  47. Septic abortion and acute renal failure in a patient with an intrauterine contraceptive device.
  48. Serious complications of oral contraception in insulin-dependent diabetics.
  49. Serum concentration of bile acids in relation to the normal menstrual cycle, the administration of oral contraceptives, and pregnancy.
  50. Serum concentrations of prolactin, growth hormone, and alpha-fetoprotein under long-term administration of an oral contraceptive containing cyproterone acetate. [SErumkonzentrationen von Prolaktin, Wachstumshormone und Alpha-Fetoprotein bei Langzeiteinnahme eines Cyproteronacetathaltigen Kontrazeptivums.]
  51. Serum high-density-lipoprotein cholesterol in women using oral contraceptives, estrogens and progestins.
  52. Serum level and 24 hr. excretion pattern of potassium following the intake of combined oral contraceptives.
  53. Serum levels of FSH, LH, estradiol-17 beta and progesterone following the administration of a combined oral contraceptive containing 20 mcg ethinylestradiol.
  54. Serum lipids and lipoproteins during treatment with oral contraceptives containing natural and synthetic oestrogens: a controlled double-blind investigation.
  55. Serum vitamin B12 and B12-binding protein levels associated with oral contraceptives.
  56. Sex education and family planning clinic for adolescents. [Clinica de orientacion sexual y planeacion familiar en adolescentes.]
  57. Sex education guidelines, including reproductive health and family planning.
  58. Sex of children born after oral contraceptive use.
  59. Sexual and contraceptive attitudes and behaviour of high school and college females.
  60. (Sexual and contraceptive experiences of young unmarried women in the United States)
  61. Sexual attitudes and contraceptive practices.
  62. Sexual behaviour and contraceptive practice of undergraduates at Oxford University.
  63. Sexual experience, contraceptive usage, and source of contraception among never-married women: Albany (NY) Health Region.
  64. Shame is the best contraceptive.
  65. Short radio spots to promote family planning. [Spots ou petites annonces de radio en faveur de la planification familiale.]
  66. Should routine liver biopsy of liver be performed at time of laparotomy in a patient taking oral contraceptives? (Letter) [Faut-il faire systematiquement une ponction biopsie du foie au cours d'une laparotomie, lorsque l'opere prend des contraceptifs oraux?]
  67. The significance of cultural tradition for contraceptive change: a study of rural Indian women.
  68. The slippery slope from contraception to euthanasia.
  69. Sloppier contraception, not more wanted births, caused 1950s baby boom, NFS researcher says.
  70. Small-bowel ischaemia and the contraceptive pill.
  71. Small-bowel ischaemia and the contraceptive pill. (Letter)
  72. Social characteristics of diaphragm users in a family planning clinic.
  73. Social marketing: an innovative family planning approach in Bangladesh.
  74. Social science research and family planning: the case of Sri Lanka.
  75. Social sciences in family planning: proceedings of the Meeting of the IPPF Social Science Working Party held in Colombo, Sri Lanka, 10-13 June 1977.
  76. Social welfare aspects of family planning programmes in rural areas of Papua New Guinea.
  77. Social welfare content in family planning materials.
  78. Sociocultural factors affecting acceptance of family planning services by Navajo women.
  79. Socioeconomic change and family planning: their impact on fertility.
  80. Sociological aspects of contraceptive sterilization: the role of knowledge and attitudes.
  81. Some comments on the use of antiandrogens for male contraception.
  82. Some comments on the use of steroid hormones for male contraception.
  83. Some observations on the use of oral contraception.
  84. Some psychological factors related to family planning among women.
  85. Some variables for a survey on impact of family planning.
  86. Spain legalizes contraception.
  87. Spatial analysis of family planning program effects in Taiwan, 1966-72.
  88. Special report: the House Committee on Population: impact of FDA's refusal to approve Depo Provera for contraceptive use considered.
  89. Sperm inhibitors as contraceptives.
  90. A spinal epidural abscess complicating an intrauterine contraceptive device.
  91. Spontaneously regressive ulcerative colitis: the result of contraceptive agents? (Letter) [Colite ulcerose spontanement regressive: consequence des anti-conceptionnels?]
  92. The status and trends of family planning programmes in developing countries: a case study of Bangladesh. (Statement, April 27, 1978))
  93. The status and trends of family planning/population programs in Latin America. (Statement, April 25, 1978.)
  94. The status of the African woman in family planning.
  95. Status report of the family planning-parasite control-nutrition integration pilot project (Philippines)
  96. Status report on new contraceptives.
  97. Sterilization as a contraceptive method. [Sterilizatsiiata kato kontratseptiven metod.]
  98. Sterilization is leading contraceptive.
  99. Steroid contraception and cancer (author's transl) [Steroidni kontracipiensi in rak.]
  100. Steroid contraception and the risk of neoplasia.
  101. Steroid contraception and the risk of neoplasia. (Editorial)
  102. Steroid contraception, venous thromboembolism, and stroke: data from countries other than the United States.
  103. Steroid contraception.
  104. Steroid contraception: metabolic and endocrine effects.
  105. Stopping oral contraceptives. [L'arret des contraceptifs oraux.]
  106. The story of the pill: how a crash program developed an efficient oral contraceptive in less than a decade.
  107. Student volunteers as birth control educators.
  108. Studies on the feasibility and effectiveness of contraceptive inundation. Approach: development of models for wider application and adoption. Brief summary report.
  109. Study of an innovator and change agent of contraception.
  110. A study of Depo-Provera users in a family planning clinic in Sri Lanka.
  111. Study of family planning workers in Uttar Pradesh.
  112. Study of physical and sexual growth of pre-adolescent and adolescent children of rural Hyderabad and their knowledge attitudes towards human reproduction and family planning.
  113. A study of relations between abortion and contraception among a family planning center clients. [Etude des correlations avortement-contraception, en centre de planification familiale.]
  114. A study of serum lipids in relation to socio-economic and nutritional status in women using oral contraceptive.
  115. A study of the field worker performance in the Matlab Contraceptive Distribution Project.
  116. A study of the impact of community-level characteristics on family planning and fertility behavior in Korea.
  117. Study of the knowledge, attitude and practice among teenagers in Hawaii related to reproduction, family planning and sexuality.
  118. A study of the media exposure and family planning in northern Thailand.
  119. A study of the role of the Yoruba husband in family planning: implications for family planning education.
  120. A study on immunization status of children in 1,000 family planning adopted families.
  121. A study on the acceptance and pattern of contraceptive use in Korean women (author's transl)
  122. A study on the contraceptive effectiveness of a newly designed IUD "FD-1" in Japan.
  123. A successful family planning week in Canada.
  124. Summary of Fourteenth National Survey on Family Planning.
  125. Summary of the Workshop of the IPPF-ESEAOR Panel on the Effects of Steroidal Contraceptives on Asians, Hong Kong, September 2-4, 1978.
  126. Summary report of the Thai integrated family planning and parasite control programme September 1976 - September 1978.
  127. The supply of contraceptives. (Letter)
  128. Suppression and recovery of sperm production in men treated with testosterone enanthate for one year: a study of a possible reversible male contraceptive.
  129. Surgical contraception.
  130. Surgical contraception: a key to normalization and prevention.
  131. A survey evaluation of the efficacy and efficiency of natural family planning services and methods in Australia: report of a research project.
  132. Survey of oral contraceptive usage.
  133. Swedish billboards tout barrier contraceptives.
  134. The Sydney Survey: a commentary on a survey evaluation of the efficacy and efficiency of natural family planning services and methods in Australia.
  135. Symposium on methodologies for evaluation of national family planning programmes in its various stages of development. (A report on the Joint JOICFP/IGCC Symposium, Tokyo, Japan, October 30, 1977)
  136. A symposium, recent advances in contraception, Thredbo, Australia, February 24-26, (1978)
  137. Sympto-thermal method and family planning.
  138. A system model of contraceptive adoption.
  139. Systems analysis and information needs assessment of the Korean National Family Planning Program: interim report of a new scheme for the improvement of family planning information systems and quality of family planning program statistics.
  140. Systems approach to vaginal delivery of contraceptive drugs: methodology and mechanism for absorption.
  141. Teaching family planning management and evaluation skills.
  142. Techniques of health and family planning education in rural India.
  143. Teenage sex and birth control.
  144. Teenagers, birth control and the nurse.
  145. Testimony on behalf of the International Planned Parenthood Federation. (Statement, August 8, 1978)
  146. Texas: teenage childbearing and contraceptive need.
  147. Thai nurses perform surgical contraception.
  148. Thailand: Contraceptive Prevalence Survey: summary report.
  149. Thailand: student work camps for the training of young people as family planning motivators.
  150. Three villages (in India: report on their family planning program)
  151. Three years' experience with the MLCu250, a new copper-wired intrauterine contraceptive device.
  152. To curb high African fertility: delay marriage, expand family planning, women's opportunities.
  153. To have-or not to have-another child: family planning attitudes, intentions, and behavior.
  154. Toward a typology of community-based distribution family planning programs.
  155. Toward an assessment of the social role of rural midwives and its implication for the family planning program: an Iranian case study.
  156. Toward intimacy: family planning and sexuality concerns of physically disabled women. 2nd ed.
  157. Toward safe, convenient, and effective contraceptives: a policy perspective.
  158. Towards integrated family planning in the Sudan: a situation report [revised edition]
  159. Towards organizational effectiveness of integrated family planning programmes: the ESCAP experience.
  160. Toxic liver diseases after hormonal contraception. [Toxische Hepatose bei hormoneller Kontrazeption.]
  161. Traditional methods of birth control in Zaire.
  162. Traditional methods of birth control.
  163. Training family planning motivators in Bangladesh.
  164. Training family planning personnel in sex counseling and sex education.
  165. Training management in family planning programs.
  166. Training nurses and midwives in family planning.
  167. Training physicians of developing nations in female surgical contraception.
  168. Trends in fertility, family size preferences, and family planning practice: Taiwan, 1961-76.
  169. Tryptophan metabolism, oral contraceptives, and pyridoxine. (Letter)
  170. Tubal actinomycosis as a complication of intrauterine contraception. [Tubaraktinomykose als Komplikation der intrauterinen Antikonzeption.]
  171. Two modifications of the intrauterine membrane contraceptive device.
  172. (U.S. Agency for International Development assistance to the Indonesian national family planning program.) (Statement, April 25, 1978)
  173. A U.S. clinician reports on family planning Chinese-style.
  174. U.S. rate of effective contraception is very high.
  175. Ultrasonic localization of missing intrauterine contraceptive devices.
  176. Ultrasonography for the localization of intrauterine contraceptive devices. [Anwendung der Ultraschall-Schnittbildtechnik zur Darstellung von Intrauterinpessaren.]
  177. Ultrastructure of the endometrium and its modification by contraceptive agents.
  178. Uncomplicated pregnancy following oral contraceptive-induced liver hepatoma.
  179. Unconscious resistance to contraception. [Resistances inconscientes a la contraception.]
  180. The unmet need for birth control in five Asian countries.
  181. Unmet needs in family planning: a world survey with special reference to Pakistan.
  182. Urinary D-glucaric acid and oral contraceptives. (Letter)
  183. Use of a radioreceptor test for HCG in women practicing contraception.
  184. Use of contraception by adults. [Bruk av prevensjon hos voksne.]
  185. Use of intrauterine contraceptive devices in the United States.
  186. Use of oral contraceptives, cigarette smoking, and risk of subarachnoid haemorrhage.
  187. The use of progestins and androgens as a male contraceptive.
  188. Use of the Progestasert intrauterine progesterone contraceptive system by European investigators.
  189. Use-pattern of oral contraceptive in rural Bangladesh: a case study of Sulla.
  190. The utilization of community members in the extension of a family planning program's reach. [La utilizacion de personal comunitario para la extension de cobertura del programa de planificacion familiar.]
  191. Utilization of Hilot in village household distribution of contraceptives: OC distribution/Hilot Philippines: progress report (March 1978 to August 31, 1978)
  192. Vaginal progesterone for contraception.
  193. The value of depo-medroxyprogesterone acetate as a long-acting injectable contraceptive. (Statement, August 9, 1978)
  194. Value of thyroid function tests after prolonged hormonal contraception. [Vrijednost testova funkcije stitne zlijezde nakon dugotrajne hormonske terapije.]
  195. Variations in fertility with breast-feeding practice and contraception in urban Filipino women: implications for a nutrition program.
  196. Vasectomy: a reversible method of contraception.
  197. Village-based family planning program in Korea: the case of mothers' club.
  198. Vitamin B-6 status of Nigerian women using various methods of contraception.
  199. Vitamin B6 and oral contraceptives. [Vitamin B6 e contraccettivi orali.]
  200. Voice disorders due to hormonal contraceptives. [Stimmstoerungen durch hormonale Kontrazeptiva.]
  201. Voluntary family planning services, population research, and Sudden Infant Death Syndrome Amendments of 1978.
  202. Wahren brings ecosophy to family planning.
  203. What is family planning? (Statement, March 7, 1978)
  204. What the IEC task is: developing culture-based strategies for continued contraceptive use.
  205. Where villagers show the way from community-based family planning services to fertility-related village development programmes.
  206. Which contraceptive to choose at age 40? [A quarante ans quelle contraception choisir?]
  207. WHO and research in natural family planning.
  208. WHO boosts its family planning role.
  209. WHO studies plants for contraceptive properties.
  210. (Why abortion and contraceptives are not working to curb teen-age pregnancy.) (Statement, June 16, 1978)
  211. Why family planning?
  212. Why it is right for family planning nurses to prescribe the pill.
  213. (Why, how and who does contraceptive research) (Statement, March 9, 1978)
  214. Women's organisations in family planning.
  215. Women--the deciding factor in family planning?
  216. A work plan for a family planning analysis of World Fertility Survey data.
  217. Working class birth control in Wilhelmine Germany.
  218. Workshop paper on integrated MCH and family planning with family welfare workers.
  219. World list of family planning agencies.
  220. Youth for family planning programs in Bangladesh.
  221. Abortion vs. contraception as a method of reduction of fertility: a review.
  222. Clinical performances and endocrine profiles with contraceptive vaginal rings containing d-norgestrel.
  223. Language differences and the family planning survey.
  224. Oral contraceptives and cervical carcinoma.

     

  225. A possible role of prostaglandin E1 in the mechanism of action of intrauterine contraceptive device.
  226. The problem of the lost intrauterine contraceptive device. [Zum Problem des "verlorenen" Intrauterinpessars.]
  227. Reduced uterine response to PGF2 alpha under oral contraceptives.
  228. Target fertility, contraception, and aggregate rates: toward a formal synthesis.
  229. Family planning: having the number of children you want.
  230. Health: the family planning factor./La planificacion familiar como factor de salud.
  231. A guide to sources of family planning program assistance./Guide des sources d'assistance dans le domaine dia planning familial./Una fuia de fuentes de asistencia para programas de planificacion familiar.
  232. Debate on oral contraceptives and neoplasia continues; answers remain elusive./Le debat sur les contraceptifs oraux et la neopliasie se poursuit; les responses restent evasives./El debate acerca de anticonceptivos orales y neoplasias continua; las respuestas siguen siendo ellusivas.
  233. U.S. morbidity and mortality trends relative to oral contraceptive use, 1955-1975, and Danish morbidity trends, 1953-1972./Tendances de la mortalite au Etats-Unis en fonction de l'emploi de contraceptifs oraux , 1955-1975 et tendances de la morbidite au Danmark 1953-1972./Tendencias de morbosidad y mortalidad reilacionadas con el uso de anticonceptivos orales esa Estados Unidos, 1955-1 975, y tendencias de morbosidad esa Dinamarca, 1953-1972.
  234. Population family planning media communications in 25 countries./Les media et les programmes de population et de planning familial./Meios de comunicacao em programas de populacao planejamento familiar: um exame./Medios de comunicacion en programas de poblacion/planificacion familiar : resena.
  235. $1 million study of lactation as contraceptive.
  236. 10 years of contraception: A new role for doctor. [10 ans de contraception: un nouveau role pour le medecin.]
  237. 1976 report of province-wide schoolchildren Ascaris control program and the first-year report of integrated program for family planning promotion and parasite control in Nantou County, Taiwan, Republic of China.
  238. Abortion and contraception. (Letter)
  239. Abortion regarded as contraception [letter]
  240. Abortion regarded as contraception. (Letter)
  241. Abortion regarded as contraception. (Letter)
  242. Abortion, sterilization, and contraception.
  243. Absence of circulating chorionic gonadotropin in wearers of intrauterine contraceptive devices.
  244. Absence of hCG-like activity in the blood of women fitted with intrauterine contraceptive devices.
  245. Acceptability of an oral contraceptive that reduces the frequency of menstruation: the tri-cycle pill regimen.
  246. Acceptor data on female sterilization: 2nd progress report for USAID Health and Family Planning Project.
  247. Access to oral contraceptives [letter]
  248. Access to oral contraceptives. (Letter)
  249. The accuracy of family planning service statistics.
  250. Acid-base balance immediately after administration of an oral contraceptive. [Verhalten des Saure-Basen-Haushalts unmittelbar nach Einnahme eines oralen Kontrazeptivums.]
  251. ACS commission on cancer survey supports suggested association between oral contraceptive usage and liver tumors.
  252. Actinomycetes-like organisms in wearers of intrauterine contraceptive devices. (Letter)
  253. Actinomycosis of the uterine tube as a complication of intrauterine contraception. [Aktinomykoza vejcovodu komplikaci intrauterinni antykoncepce.]
  254. Active E-rosette formation in women taking oral contraceptives. (Letter)
  255. Adolescent contraception. [La contraception de l'adolescente.]
  256. Adoption of modern health and family planning practices in a rural community of India.
  257. Advanced in MCH and family planning.
  258. Advantages and disadvantages of nonprescription contraceptives.
  259. Advertising and contraceptives.
  260. Affective disorders in users of contraceptive drugs. [Zaburzenia afektywne jako objaw uboczny u stosujacych srodki antykoncepcyjne.]
  261. Aflatoxin and oral contraceptives.
  262. Aflatoxin and Oral Contraceptives. (Letter)
  263. Age-old methods of contraception.
  264. AID administrator-designate will not change agency's family planning policies.
  265. AID family planning/operations research projects: village and household distribution of contraceptives and health medicaments.
  266. AID finds increased support overseas: justifies more family planning aid.
  267. Aide-memoire: symposium on methodologies for evaluation of national family planning programmes in its various stages of development.
  268. Aide-memoire: workshop on an integrated approach at grassroots level towards family planning and health programs with particular emphasis on parasite control and nutrition.
  269. Allocation of family planning funds for this year set, future direction in doubt.
  270. Alpha 1-antitrypsin, protein marker in oral contraceptive-associated hepatic tumors.
  271. Alpha 1-antitrypsin: a tumor protein marker in oral contraceptive-associated liver tumors.
  272. Alterations in the liver by contraceptives. [Leberveraenderungen durch Kontrazeptiva.]
  273. Altered plasma-lipids associated with oral contraceptive or oestrogen consumption.
  274. Amenorrhea following the use of oral contraceptives.
  275. An analysis of the content and strategy of family planning radio programs in Taiwan, 1969-1973.
  276. Antagonistic action of rifampicin and isoniazid on the metabolism of oral contraceptives. [Effets opposes de la rifampicine et de l'isoniazide sur le metabolisme des contraceptifs oraux?]
  277. Antithrombin 3 activity, measured with a chromogenic substrate, in patients with hepatic cirrhosis, with prosthetic heart valves and during parenteral administration of medroxyprogesterone acetate as a contraceptive agent. (Abstract only)
  278. Appeal for oral contraception in the immediate post-partum. [Plaidoyer pour la contraception orale dans le post-partum immediat.]
  279. Appearance of contraceptive steroids in human milk: effects on the child.
  280. An appearance of genocide: a review of governmental family-planning program policies.
  281. Appendix: comments on the 1976 Supreme Court Decisions: Planned Parenthood v. Danforth and Bellotti v. Baird.
  282. The application of diffusion models to population programs: the Philippine case of the commercial contraceptive marketing program.
  283. An application of operant conditioning theory to family planning communication.
  284. Applying family planning in rural communities.
  285. An approach to quantifying breakthrough bleeding in oral contraceptive studies.
  286. Are hormonal contraceptives teratogenic?
  287. Are oral contraceptives to be discontinued before surgery? [Ovulationshemmer vor Operationen absetzen?]
  288. Asks abdomen palpation for users of oral contraceptives.
  289. Assessment of human chorionic gonadotropin (HCG) levels during luteal phase in women using intrauterine contraception.
  290. Assessment of pituitary-ovarian function in perimenopausal women after stopping oral contraceptives. (Abstract only)
  291. The association between oral contraception and hepatocellular adenoma - a preliminary report.
  292. Association between oral contraceptive use and thromboembolism: a new approach to its study.
  293. Association between oral contraceptives and myocardial infarction: a review.
  294. Association of liver tumors and cancer of the endometrium with oral contraceptive use.
  295. The association of oral contraceptives and myocardial infarction in less developed countries.
  296. The association of specific oral contraceptive compounds and development of hepatocellular adenomas. (Abstract only)
  297. Attitude of industrial and plantation workers towards family planning (a base-line survey)
  298. Attitude of Muslim women towards family planning.
  299. Attitude towards family planning: a study of inpatient attendants.
  300. Attitudes of adolescent males toward abortion, contraception, and sexuality.
  301. Attitudes of black South AFrican men towards fertility and family planning.
  302. Attitudes of nurses to providing contraceptive services for youth.
  303. Attitudes of some couples using natural family planning.
  304. Attitudes to family planning in Lesotho. Report of a survey conducted by LDTC as part of the project "Education for Family Planning in Lesotho".
  305. Attitudes toward and future intention to practice family planning.
  306. Attitudes, contraceptive practice and children ever born among currently married women exposed to different types of communication media, Pakistan.
  307. Australia: New directions in family planning.
  308. An automated clinic management system for a family planning network.
  309. Awareness, attitude and action about family planning in villages in Maharashtra.
  310. The bacteriology of the cervical canal in relation to the use of an intrauterine contraceptive device.
  311. The barrio-level family planning worker: the IIRR experience.
  312. Basaloid adenomas of the mammary gland in beagle dogs administered investigational contraceptive steroids.
  313. The beagle dog and contraceptive steroids.
  314. Behavior of lysozyme levels in the sera of women with hormonal contraception. [Zum Verhalten des Lysozymspiegels in den Seren von Frauen mit hormonaler Kontrazeption.]
  315. Behavior of total protein fractions in serum in case of different hormonal contraceptives. [Zum Verhalten von Gesamtprotein und Proteinfraktionen im Serum bei verschiedenen hormonalen Kontrazeptiva.]
  316. The benefit of lactation amenorrhea as a contraceptive.
  317. Benign breast disease and oral contraceptive use.
  318. Benign hepatic lesions and orally administered contraceptives: a report of seven cases and a critical analysis of the literature.
  319. Benign hepatic lesions in women taking oral contraceptives.
  320. Benign hepatic tumors and cysts in women using oral contraceptive agents: computed tomography as a diagnostic aid.
  321. Benign intracranial hypertension and thrombosis of the venous sinuses caused by contraceptive treatment. Anatomo-clinical and neuroradiological observations. [Ipertensione endocranica benigna e trombosi dei seni venosi da trattamento contraccettivo: osservazioni anatomo-cliniche e neuroradiologiche.]
  322. Benign intracranial hypertension and thrombosis of the venous sinuses during contraceptive treatment: anatomo-clinical and neuroradiological observations. [Ipertensione endocranica benigna e trombosi dei seni venosi durante trattamento contraccettivo: osservazioni anatomo-cliniche e neuroradiologiche.]
  323. Benign liver tumors in patients taking oral contraceptives.
  324. Bibliography on human reproduction, family planning and population dynamics: annotated articles and unpublished work in the South-East Asia Region: morbidity and mortality due to pregnancy and child birth.
  325. The Billings method of natural birth control, based on fertile and infertile periods, determined by cervical mucus observation. [Methode Billings la regulation naturelle des naissances fondee sur les phases de fecondite et d'infecondite etablies par l'observation de la glaire cervicale.]
  326. Binding of steroids to human spermatozoa and its possible role in contraception.
  327. Biodegradable polymers and sustained delivery of contraceptive drugs.
  328. Bioengineering aspects of reproduction and contraceptive development.
  329. The biological effects of a new modified sequential oral contraceptive.
  330. Biology of natural family planning.
  331. Birth control and family planning. [Control de la natalidad y planificacion familiar.]
  332. Birth Control by jamming LHRH.
  333. Birth control clinics in the city of Birmingham - a geographic study.
  334. Birth control in India: the carrot and the rod.
  335. Birth control, judges, and clinical judgment. (Letter)
  336. Birth control: alternatives to the pill.
  337. Birth control: contraception, abortion, sterilization. [Controllo delle nascite: contraccezione, aborto, sterilizzazione.]
  338. Births aborted among the users of the voluntary family planning program of the Instituto Mexicano del Seguro Social. [Nacimientos no acontecidos en usuarias del programa de planeacion familiar voluntaria del instituto mexicano del seguro social.]
  339. Births averted by ten years (1966-1975) of the National Family Planning and Population Program.
  340. Black ministers' attitudes toward population size and birth control.
  341. Blood pressure response to estrogen-progestin oral contraceptive after pregnancy-induced hypertension.
  342. Body image and contraceptive acceptability in a Mexican community.
  343. Bowel obstruction and perforation with an intraperitoneal loop intrauterine contraceptive device.
  344. Brazilian community programs in family planning. [Programas comunitarios Brasileiros de planejamento familiar.]
  345. Breast-feeding - the best contraceptive?
  346. Budd-Chiari syndrome after taking oral contraceptives: a case report and review of 14 reported cases.
  347. Call unsuccessful rhythm contraception risk to fetus.
  348. Cancer risk as related to use of oral contraceptives during fertile years.
  349. Carbonic anhydrase activity in human cervical mucus and its response to various contraceptive regimes.
  350. Cardiovascular hazards of oral contraceptive use. (Editorial)
  351. The care of oral contraceptive users by general practitioners in Oxfordshire.
  352. Caribbean adolescent contraception: the law, polemics, and other issues.
  353. A case for injectable contraceptives.
  354. Case report on a retinal complication in long-term-therapy with oral hormonal contraceptives (author's transl) [Weitere Mitteilung einer Komplikation unter einer Lang zeittherapie oraler hormonaler Kontrazeptiva.]
  355. A case-control study of oral contraceptive use and non-fatal myocardial infarction in American women. (Abstract only)
  356. Casebook for family planning management: motivating effective clinic performance.
  357. Catholics practice birth control just as much as others.
  358. Cell proliferation in normal human breast ducts, fibroadenomas, and other ductal hyperplasias measured by nuclear labeling with tritiated thymidine. Effects of menstrual phase, age, and oral contraceptive hormones.
  359. Central and peripheral actions of an oral contraceptive with reduced estrogen content. [Zentrale und periphere Auswirkungen eines Ostrogen-dosisreduzierten oralen Kontrazeptivums.]
  360. Cerebral vascular troubles in women taking oral contraceptives. [Accidents vasculaires cerebraux au cours de la contraception orale.]
  361. Cerebral venous thrombosis and oral contraception. [Thromboses veineuses cerebrales et anti-conceptionnels oraux.]
  362. Cerebral venous thrombosis and oral contraceptives. Report of 2 cases. [Deux observations de thrombose veineuse cerebrale chez des femmes prenant des anticonceptionnels oraux.]
  363. Cerebral venous thrombosis in a woman using oral contraceptives: a case report (Abstract only) [Thrombose veineuse cerebrale chez une femme sous contraceptifs oraux: A propos d'un cas.]
  364. Cerebrovascular diseases in women receiving oral contraceptives: report of three cases (author's transl)
  365. Cervical contraception.
  366. Cervical epithelium and mucus and their response to oral contraceptive steroids.
  367. The change of antithrombin 3 activity of pregnant women and women on oral contraceptives (author's transl)
  368. Changes in antithrombin III levels in pregnancy, labour and in women on the contraceptive pill.
  369. Changes in glucose tolerance, serum insulin, and blood lipids during contraceptive medication in metabolically healthy women. [Glukosetoleranz, Insulin und Blutlipide unter einem Ovulationshemmer bei stoffwechselgesunden Frauen.]
  370. Changes in menstrual cycle length and regularity after use of oral contraceptives.
  371. Changes in serum high density lipoproteins in women on oral contraceptive drugs.
  372. Changes in the biochemical properties of cervical mucus during the use of minitablet contraception. [Zmeny biochemickych vlastnosti cervikalniho v prubehu uzivani minitabletove antikoncepce.]
  373. Changes of glucose tolerance and blood lipid level in women a s a result of administration of oral contraceptives. [Izmenyenye tolerantnosti u urovnya lipidov crovi u zhenshin u resultatye primyenyenya oralnikh contratspetivikh preparatov.]
  374. Changes of serum hormone concentrations during oral contraception using monohormonal and combination preparations. [Veraenderungen der Hormonserumkonzentrationen unter oraler Kontrazeption mit monohormonalen un Kombinationspraeparaten.]
  375. The changing pattern in oral contraception.
  376. Chinese see "attitude" as birth control key.
  377. Chloasma, oral contraceptives, and plasma immunoreactive beta-melanocyte-stimulating hormone.
  378. Chromatographic separation of multiple renin substrates in women: effect of pregnancy and oral contraceptives (39957)
  379. Chromosomal abnormalities: no link with contraceptives.
  380. Chromosomes, the oral contraceptive and possible breast cancer. (Abstract only)
  381. Cilioretinal artery occlusion associated with oral contraceptives.
  382. Clinical and biochemical investigations of a variable-dose combined type oral contraceptive.
  383. Clinical aspects of intrauterine contraception: circumspection 1976.
  384. Clinical course and pathenogeneis of oral contraceptive hypertension. [Klinik und Pathogenese der Ovulationshemmer-Hypertonie.]
  385. Clinical evaluation of an oral contraceptive combination with a low dosage of estrogens and progestogens and their correlation in a group of women using intrauterine device. [Evaluacion clinica de una asociacion anticonceptiva oral con dosis bajas de estrogenos y progestagenos y su correlacion frente a un grupo de mujeres portadoras de dispositivo intrauterino.]
  386. Clinical experience with a low-estrogen, low-progestogen combined oral contraceptive. Evaluation of a Swedish multicentre study.
  387. Clinical experiences with the two-phase preparation BIOGEST/Spofa for hormonal contraception. [Klinische Erfahrungen mit dem Zweiphasenpraeparat BIOGEST/Spofa zur hormonalen Kontrazeption.]
  388. Clinical investigation of the biological effects of a new combination low-dose oral contraceptive ('Ovostat E')
  389. Clinical problems with oral contraceptives.
  390. Clinical study of intrauterine contraceptives. [Klinitcheskoye isutchenye vnutrimatotchnikh contratseptivov.]
  391. Clinical trial of low-dose oral contraceptive pill containing 0.75 mg. lynestrenol and 0.0375 mg. ethinyl estradiol.
  392. The clinical use of monthly injectable contraceptive preparations.
  393. Co-operative involvement in population and family planning programmes - some practical examples.
  394. Co-operatives and family planning associations - working together.
  395. Coagulation abnormalities in women taking oral contraceptives.
  396. Collaborative study of an assay for progestational steroids in individual contraceptive tablets.
  397. Collagen bands: a new vaginal delivery system for contraceptive steroids.
  398. Combined oral contraceptives.
  399. Combined-type oral contraceptives and plasma triglyceride and cholesterol levels of young women.
  400. Comments on epidemiologic studies relating myocardial infarction and oral contraceptives.
  401. Commercial contraceptive marketing development in Bangladesh.
  402. The commercial distribution of contraceptives in El Salvador.
  403. The commercial distribution of contraceptives in Mexico.
  404. Communicating population and family planning.

     

  405. The communication process in family planning in a West Bengal village.
  406. Community and client acceptance of family planning services in a summer beach environment.
  407. Community interventions in health and family planning programmes: a conceptual framework.
  408. Community-based distribution of contraceptives and selected health supplies, Nicaragua, February 12-March 6, 1977: resource support services report. [Memorandum]
  409. Community-based distribution of contraceptives in northeast Brazil.
  410. Community-based distribution of contraceptives.
  411. Community-based distribution of contraceptives. The spectrum of approaches and strategies.
  412. Comparative clinical trial of two oral contraceptives with a low-estrogen content.
  413. Comparative contraceptive experience with three-month and six-month medroxyprogesterone acetate regimens.
  414. Comparative impact of family planning programs upon fertility in developing countries.
  415. Comparative metabolism of 17alpha-ethynyl steroids used in oral contraceptives.
  416. Comparative studies of the ethynyl estrogens used in oral contraceptives: effects with and without progestational agents on plasma cortisol and cortisol binding in humans, baboons, and beagles.
  417. A comparative study of a regular and low dose oral contraceptive in rural Bangladesh.
  418. A comparative study of three low dose progestogens, chlormadinone acetate, megestrol acetate and norethisterone, as oral contraceptives.
  419. Comparison between the use of oral contraceptives and the incidence of surgically confirmed gallstone disease.
  420. Comparison of contraceptive conduct of minors and of women of various ages. [Kontrazeptives Verhalten bei Minderjahrigen und bei Frauen verschiedener Altersstufen.]
  421. Comparison of ethinylestradiol and mestranol in sequential type oral contraceptives in their effects on blood glucose and serum insulin in oral glucose tolerance tests.
  422. A comparison of family planning users in the project and non-project areas: Bohol, 1975.
  423. A comparison of symptoms associated with the use of three oral contraceptives: a double blind crossover study of Ovral, Noriny.
  424. A comparison of the in vivo contraceptive potencies of a variety of marketed vaginal contraceptive dosage forms.
  425. Complications and late sequelae of contraception including sterilization. [Komplikationen und Spatfolgen der Kontrazeption einschliesslich der Sterilisation.]
  426. Component analysis of the correlations of some factors with family planning performance by methods in India during 1967-73.
  427. Conception, contraception and misconception.
  428. Conceptual evolution of family planning in Colombia and Latin America. [Evolution conceptual de la planificacion familiar en Colombia y Latinoamerica.]
  429. Consistency of effective contraceptive use increases dramatically among unwed teens.
  430. Consultant report for the evaluation of Family Planning International Assistance.
  431. Consultant report on contraceptive vending by machine in Europe and Bangladesh.
  432. Consultant report on the Conference on Techniques, Family Planning, Rabat, Morocco.
  433. Consultant report on the development of rural services, National Family Planning Program, Mexico.
  434. Consultation report on surgical and hormonal contraception in Pakistan.
  435. A continuous experiment of the use of norethindrone-ethinyl estradiol combination in small doses as a contraceptive. [Experiencia continuada con el empleo de la combinacion noretindrona-etinil estradiol a dosis baja como anticonceptivo.]
  436. Continuous intrauterine copper contraception for 3 years: comparison of replacement at 2 years with continuation of use.
  437. Contraception and abortion.
  438. Contraception and family planning. [Schwangerschaftsverhutung und Familienplanung.]
  439. Contraception and family planning: finding the best method (Part 1)
  440. Contraception and haemoglobinopathies in Ibadan, Nigeria. An evaluation of the effect on anaemia.
  441. Contraception and mental hygiene. [Contraception et hygiene mentale.]
  442. Contraception and sterilization in the United States, 1965-1975.
  443. Contraception and termination of pregnancy in adolescents. [Contraception et interruption volontaire de grossesse chez l'adolescente.]
  444. Contraception and the college freshman.
  445. Contraception and the law.
  446. Contraception bound cardiovascular accidents and circulating lipids anomalies. [Accidents carciovasculaires de la contraception par oestroprogestatifs et anomalies des lipides circulants.]
  447. Contraception counselling and therapeutic abortion. (Letter)
  448. Contraception for Adolescents. [Kontrazeption bei Adoleszenten.]
  449. Contraception for women of 40 years. [Contraception chez la femma de 40 ans.]
  450. Contraception in adolescents. [La contraception del'adolescent.]
  451. Contraception in Britain.
  452. Contraception in Morocco and Tunisia. [Contraception et fecundite au Maroc et en Tunisie.]
  453. Contraception in teenagers.
  454. Contraception in the over 40 age group.
  455. Contraception in the puerperium.
  456. Contraception in women with cardiac disease. [La contraception chez les femmes cardiaques.]
  457. Contraception in youths. [Antikonzeption Jugendlicher.]
  458. Contraception of married couples in the United States: recent trends. [La contraception des couples aux Etats-Unis: evolution recente.]
  459. A contraception record card for use in general practice.
  460. Contraception Sterilization and Abortion Bill. (Letter)
  461. A contraception survey in Rennes. [Une enquete sur la contraception a Rennes.]
  462. Contraception vaccine stimulates antibody to chorionic gonadotropin.
  463. Contraception with a new vaginal suppository-patentex oval. [Kontraception med en ny vaginal stikpille - patentex oval.]
  464. Contraception with chemicals.
  465. Contraception with copper IUDs. [Schwangerschaftsverhuetung mit Kupfer-Intrauterinpessaren.]
  466. Contraception with the Lippes Loop D with or without contraceptive foam. [Zur Verwendung der Lippes-D-Spirale mit und ohne Spermizidum.]
  467. Contraception, sterilization and abortion bill. (Letter to the editor)
  468. Contraception, sterilization and abortion in New Zealand.
  469. Contraception, Sterilization and abortion.
  470. Contraception.
  471. Contraception. (Letter)
  472. Contraception: the gateway.
  473. Contraception: a brief legal history.
  474. Contraception: retrospect and prospect.
  475. Contraception: the camel's nose.
  476. Contraception: the timing of first use and coital frequency.
  477. Contraceptive acceptance and use in the Republic of Korea.
  478. Contraceptive agents and cardiovascular diseases. [Anticonceptionnels et maladies cardio-vasculaires.]
  479. Contraceptive awareness and practice in Dominican Republic.
  480. Contraceptive Careers: toward a subjective approach to fertility regulating behaviour.
  481. Contraceptive cream useful in helping prevent gonorrhea.
  482. Contraceptive dynamism. (Letter)
  483. Contraceptive effectiveness of copper IUDs.
  484. Contraceptive effectiveness: misleading statistics.
  485. Contraceptive efficacy.
  486. Contraceptive efficiency of triphasic inhibitors (author's transl) [Zur kontrazeptiven Wirksamkeit von Dreistufenpraeparaten.]
  487. Contraceptive failure among married women in the United States, 1970-1973.
  488. Contraceptive hormones and congenital heart disease. (Letter)
  489. Contraceptive hormones and congenital heart disease. (Letter)
  490. Contraceptive hormones and human welfare (Symposium abstracts)
  491. Contraceptive hormones and human welfare.
  492. Contraceptive information and promiscuity. (Letter)
  493. Contraceptive method continuation according to type of provider.
  494. Contraceptive methods.
  495. Contraceptive pellet: small size but long life.
  496. Contraceptive practice after women have undergone "spontaneous" abortion in Indonesia and Sudan.
  497. Contraceptive practice among hospital attendants.
  498. Contraceptive practice before and after termination of pregnancy.
  499. Contraceptive practice by women presenting to a free-standing abortion clinic.
  500. Contraceptive prevalence and demographic trends in El Salvador.

To view other lists of the current category of articles, please visit "Category Lists Homepage"


Web PubHealth.info

© Copyrights PubHealth.info®, an information portal on public health. All rights reserved.

This page is optimized to be viewed by Java script enabled Microsoft® Internet Explorer 6 or later version, at screen resolution of 800 by 600 pixels.